Predictably,
comorbid substance misuse predicts non-adherence, and is associated with a worse outcome13 and an increased risk of suicidality.2 A recent trial of a 12 - session, group - based cognitive behaviour therapy (CBT) program for people with bipolar disorder and
comorbid substance misuse showed promising trends in reducing substance misuse and bipolar relapse compared with group - based counselling for substance misuse alone.14
Future trials should include patients with
comorbid substance misuse, depression, or anxiety disorders, where an alternative treatment to the stimulants could be of real benefit.2
Not exact matches
The results can not therefore be generalised to the substantial minority of bulimic patients with
comorbid «multi-impulsive» personality characteristics, 1 to patients with
substance misuse, or to adolescents.
High use of healthcare services was confounded by
comorbid mental disorder and
substance misuse.
Exclusion criteria were previous treatment for depression within 12 months,
comorbid dementia, psychosis,
substance misuse or serious suicidal ideation needing urgent specialist referral.